Electra Meccanica Files Application for NASDAQ Capital Markets Listing

VANCOUVEROct. 17, 2017 – ElectraMeccanica Vehicles Corp. (“Electra Meccanica” or the “Company”) (OTCQB: ECCTF), manufacturer of the all-electric SOLO commuter car and all-electric Tofino sport coupe, is pleased to announce that the Company has filed an application to have its shares of common stock listed on the NASDAQ Capital Market.

“Elevating the listing of our common stock to the NASDAQ Capital Market will provide access to a larger pool of capital, which is an important step forward in our mission to enhance shareholder value while complementing the operational progress we are making. As the Electra Meccanica story improves, the NASDAQ Capital Market listing is expected to increase trading liquidity of our common stock, broaden our shareholder base and raise our profile in the investment community,” said Jerry Kroll, Electra Meccanica’s CEO and Chairman of the Board.

The Company’s NASDAQ Capital Market listing application is subject to review and approval by NASDAQ’s Listing Qualifications Department to ensure compliance with all NASDAQ Capital Market standards. Electra Meccanica does not know how long the NASDAQ review process will last, however, it is anticipated the process will take approximately two months or longer before completion. While the Company intends to satisfy all of NASDAQ’s requirements for initial listing, no assurance can be given that this application will be approved. The Company’s common stock will continue to trade on the OTCQB under its current symbol, ECCTF, during the NASDAQ review process.

About ElectraMeccanica Vehicles Corp.
Electra Meccanica (OTCQB: ECCTF) designed and builds the innovative, all-electric SOLO and the Tofino all-electric sport coupe. Both vehicles are tuned for the ultimate driving experience while making your commute more efficient, cost-effective and environmentally friendly.

More information can be found at EMVauto.com.


Investor Relations Information

Sam Woolf
Investor Relations Coordinator;
Telephone: 604-715-7607
Email: sam@electrameccanica.com

Media Contact Information:
Jeff Holland, Head of Media Relations
Tel. 562-640-1758
Email: JeffHolland@electrameccanica.com


Safe Harbor Statements
Except for the statements of historical fact contained herein, the information presented in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian securities laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “anticipates”, “estimates”, “projects”, “expects”, “contemplates”, “intends”, “believes”, “plans”, “may”, “will”, or their negatives or other comparable words) are not statements of historical fact and should be viewed as “forward-looking statements”. Such forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, the prices of other electric vehicles, costs associated with manufacturing vehicles, the availability of capital to fund business plans and the resulting dilution caused by the raising of capital through the sale of shares, changes in the electric vehicle market, changes in government regulation, developments in alternative technologies, inexperience in servicing electric vehicles, labour disputes and other risks of the electric vehicle industry including, without limitation, those associated with the delays in obtaining governmental approvals and/or certifications. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended.

There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release.

Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable law. Such forward-looking statements reflect our current views with respect to future events and are subject to certain risks, uncertainties and assumptions, including, the risks and uncertainties outlined in our most recent financial statements and reports and registration statement filed with the United States Securities and Exchange Commission (the “SEC”) (available at www.sec.gov) and with Canadian securities administrators (available at www.sedar.com). Although the Company believes that the beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance those beliefs, plans, expectations or intentions will prove to be accurate. Investors should consider all of the information set forth herein and should also refer to the risk factors disclosed in the Company’s periodic reports filed from time-to-time with the SEC. This news release shall not constitute an offer to sell or the solicitation of an offer to buy securities of the Company nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

FLYHT Signs USD $2.1 Million Sales Contract with Azur Aviation

Calgary, Alberta – October 17, 2017 – FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) is pleased to announce the sale of its Automated Flight Information Reporting System (AFIRS™) and FLYHTLog™ services to Azur Havacilik A.S (Azur Aviation), based in Antalya, Turkey.

The value of FLYHT’s agreement with Azur Aviation is USD $2.1 million, assuming the Company provides hardware over the full term of the five (5) year contract. Additional subscription data services may be added in the future, further increasing the value of the sales contract.

FLYHT has all of the necessary Supplemental Type Certificates (STC’s) to complete installation on Azur Aviation’s fleet of B767, B737 and B757 aircraft. Installations are anticipated to begin in the first quarter of 2018.

“FLYHT will provide an advanced and innovative solution for Azur’s long-range communication needs and for complying with GADSS standards,” said Mr. Salih Dinc, Engineering Manager of Azur Havacilik. “In fact, our airline will exceed those standards with FLYHT’s solution.” Mr. Dinc added, “Their solution will also enable our mixed fleet of aircraft to transmit data in a similar format, helping us reduce downline costs related to translating data.”

“Azur Aviation is FLYHT’s first customer in the Middle East for 2017, which was one of our corporate goals for this year,” said David Perez, the Company’s Vice President of Sales and Marketing. Mr. Perez added, “Azur is a recognized airline in the region and our agreement with them helps establish a firmer foothold for FLYHT in the region.”

About FLYHT Aerospace Solutions Ltd.

FLYHT’s mission is to improve aviation safety, efficiency and profitability (located in Calgary, Canada; publicly traded as: FLY:TSX.V; FLYLF:OTCQX). Airlines, leasing companies, fractional owners and original equipment manufacturers have installed the Automated Flight Information Reporting System (AFIRS™) on their aircraft to capture, process and stream aircraft data with real-time alerts. AFIRS sends this information through satellite networks to the UpTime™ cloud-based data center, which provides aircraft operators with direct insight into the operational status and health of their aircraft and enables them to take corrective action to maintain the highest standard of operational control.


Contact Information

FLYHT Aerospace Solutions Ltd.
Paul Takalo
Interim Chief Financial Officer
403-291-7425
ptakalo@flyht.com
Investor Relations – The Howard Group
Dave Burwell
Vice President
(888) or (403)-221-0915
dave@howardgroupinc.com

 

Join us on social media!

www.facebook.com/flyht
www.twitter.com/flyhtcorp
www.slideshare.net/flyhtcorp
www.youtube.com/flyhtcorp
www.flyht.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

LGC Capital Completes Acquisition of Initial Strategic Interest in Licenced Australian Medical Cannabis Company – Little Green Pharma

MONTREALOct. 12, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to announce that it has today completed the acquisition of stage one of its strategic interest in licenced Australian Medical Cannabis company Habi Pharma Pty Ltd of Perth, Australia, doing business as “Little Green Pharma”, as announced on September 26, 2017 and October 5, 2017. On October 5, 2017, the Company announced that the TSX Venture Exchange had authorized LGC to proceed to the closing of the transaction and this transaction has now been completed.

At the closing, LGC subscribed for 2,161,091 shares of Little Green Pharma, representing an initial 4.99% of its issued and outstanding shares. As consideration for the shares, LGC paid AUD $432,218 and issued 5,660,000 LGC common shares to Little Green Pharma at a deemed issue price of $0.11 per share. LGC, subject to certain Australian regulatory and other approvals, can now move towards increasing its interest in Little Green Pharma up to 19.03%.

About Little Green Pharma:

Little Green Pharma is one of the few companies in Australia to be granted a licence to cultivate and produce Medical Cannabis within Australia.

Little Green Pharma (www.lgpharma.com.au) has advised LGC that it plans to commence cultivation and production of one of the first clean locally-grown Medical Cannabis products for use solely within Australia, giving hope and relief to those suffering from certain debilitating illnesses. Little Green Pharma’s patented technology aims to control the medicinal cannabis particle size encapsulated in the liposomes to optimise the bio-availability so the cannabinoids are readily absorbed into the bloodstream. This enables the resulting preparation to achieve desired therapeutic results with significantly lower cannabinoid doses, when compared to other forms of medicinal cannabis. Little Green Pharma’s patented process significantly reduces production costs, enabling Little Green Pharma to be more competitive in the market.

The Australian Medical Cannabis Market:

Little Green Pharma has advised LGC that Australia passed federal legislation in 2016 aimed at permitting the use of Medicinal Cannabis via a tightly-controlled licensed medical prescription system.

In March 2016The White Paper, entitled Medicinal Cannabis in Australia: Science, Regulation & Industry, was developed by the University of Sydney Business School’s Community Placement Program. Its publication followed the news that the Australian Government would shortly allow the cultivation of cannabis in Australia for medical or scientific purposes.

As the first-ever White Paper that analyses the medicinal cannabis industry in Australia, the paper examines international experiences and approaches, supply chain economics, quantities of cannabis required and potential regulatory dynamics. It also serves as a framework for the industry to commence engaging key stakeholders such as the Australian Government and the medical community.

The University of Sydney summary of the White Paper can be viewed via the below link:

http://sydney.edu.au/news-opinion/news/2016/03/29/legalising-medicinal-cannabis-would-create–100-million-industry.html

The White paper can be viewed at:

http://mgcpharma.com.au/wp-content/uploads/2016/03/mgc_whitepaper_final-sml.pdf

Highlights of the White Paper:

  • Australia would need to produce 8,000 kg of medicinal cannabis per year to service the existing market.
  • Australian market currently estimated to be worth AUD $100 million to AUD $150 million per annum, and is likely to grow significantly in the next decade.
  • Medical Cannabis has the potential to help tens of thousands of patients suffering from a wide range of medical conditions such as Multiple Sclerosis, Epilepsy, Cancer, and Severe and Chronic Pain.
  • Up to 51,000 square metres of greenhouse space – almost three times the size of the Sydney Cricket Ground – would be needed to produce the amount of cannabis required to meet demand.

Further investment stages of the Little Green Pharma acquisition:

As previously announced, the subscription agreement between LGC and Little Green Pharma provides that subject to the issuance by Little Green Pharma of shares to various third parties, LGC will subscribe for a further 752,937 shares of Little Green Pharma for cash consideration of AUD $150,587, so as to maintain its shareholding in Little Green Pharma of 4.99%. In addition, subject to certain Australian regulatory approvals, which are currently in progress, and subject to approval by Little Green Pharma in its sole discretion, LGC may further subscribe, at its option, for additional shares of Little Green Pharma in order to increase its shareholding to a maximum of 19.03%. In the event that this option is exercised, LGC will subscribe for a maximum of 4,585,972 shares of Little Green Pharma for maximum cash consideration of AUD $917,194.

Note: On October 11, 2017, the Bank of Canada’s daily average exchange rate for the Australian dollar was AUD $1.00 = CAD $0.9728.

About LGC (http://www.lgc-capital.com)

LGC Capital Ltd.’s (TSXV: LG) mission is to invest into global high-yield diversified businesses. LGC’s flagship project is its partnership with AfriAg (Pty) Ltd. and South Africa’s House of Hemp to grow, cultivate and distribute medical-grade cannabis from its 40,000 m2 facility located in Block D of the Dube Tradeport’s Agrizone Complex. This greenhouse is the most eco-friendly and high tech agricultural facility in Africa.

For further information please contact:

LGC Capital:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”), its investment in Little Green Pharma, and LGC’s operations, strategy, investments, financial performance and condition. These statements generally can be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC, including its proposed investment in Little Green Pharma, could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2016, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and LGC has no obligation to update such statements, except to the extent required by applicable securities laws.

Information Relating to Little Green Pharma:
All information contained in this press release relating to Little Green Pharma has been provided to LGC by Little Green Pharma. LGC has relied upon this information without having made independent inquiries as to its accuracy or completeness and assumes no responsibility for any inaccuracy or incompleteness of such information.

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

QYOU strikes again in Portugal with NOWO

  • QYOU Media’s linear channel will bring best-of-web video content to almost a million additional homes through NOWO TV service
  • The agreement sees further expansion of the QYOU channel reach across Western Europe

TORONTODUBLIN and LOS ANGELESOct. 10, 2017  – QYOU Media (TSXV:QYOU), the world’s leading curator of premium ‘best-of-web’ video for multiscreen distribution has announced a new agreement with telecoms operator NOWO. The partnership will see QYOU’s linear channel of curated online video content available to NOWO’s customers through its TV service in Portugal, bringing QYOU’s content to an additional 900,000 homes in the country.

Online video viewing in Portugal is booming, with Statista findings suggesting more than 40 per cent of consumers watch online video several times a day in the region. NOWO has chosen to distribute QYOU’s ad-free channel to appeal to the tastes of younger viewers, who have a growing appetite for digital-first video content. Selected by QYOU’s content curation experts, the programming features the best of online video across a range of genres including music and comedy, which is particularly popular with consumers in Portugal.

Says José Henriques, CMO of Nowo: “We are always on the lookout for new ways to enhance our services. Online video content is hugely popular in Portugal and in order to meet the needs of our customers and further extend our reach among millennial audiences, we are including QYOU in our programming line-up. We are excited to be working with QYOU to bring fresh digital-first video content to our base.”

With its second agreement in Portugal, QYOU is gaining momentum in the region by meeting the growing consumer demand for online video content. With IPTV services driving the Portuguese Pay-TV market, operators are recognizing that they need to explore new ways to increase the attractiveness of their services.

Curt Marvis, CEO & Co-founder, QYOU Media says: “This partnership with NOWO is our second in Portugal and demonstrates that operators across Western Europe  are really seeing the value and potential of short-form video content to engage with millennial audiences. Portugal in particular has a thriving and vibrant creative online video community and through this partnership we hope to tap into this interest even further as we strive to bring more local flavor to our multiscreen offering.”

About QYOU Media
QYOU Media Inc. (TSXV:QYOU) is a fast-growing global media company that curates and packages premium ‘best-of-the-web’ video for multiscreen distribution. Founded and created by industry veterans from Lionsgate, MTV, and CinemaNow, QYOU’s millennial-focused products including linear television networks, genre-based series, mobile apps, and video-on-demand formats reach millions of customers on six continents. Distribution partners include Sinclair Broadcast Group, Vodafone, 21st Century Fox, Liberty Global, Telenor and TATA Sky.

About NOWO
NOWO is a Portuguese telecommunications company that appears in the market in September 2016. Currently the 2nd largest cable network operator in Portugal, NOWO has one of the largest fiber optic networks, about 14,000 km (covering more than 70 municipalities and 200 parishes), with the capacity to provide service to more than 900 thousand houses. With the claim “NOWO: It’s fair”, the brand relies on freedom of choice, fair pricing and transparency in the relationship with customers. NOWO is the only operator that allows its customers to choose a mix of TV, NET, Phone and Mobile from a base internet offer and that clearly states the possibility of celebrating non-fidelity contracts (or for a shorter period than the usual – 6 or 12 months). To learn more visit: http://www.nowo.pt

Contacts

Holly Searle
Platform Communications – for QYOU Media
+44 (0) 207 486 4900
holly@platformcomms.com

Jeff Walker
Investor Relations – for QYOU Media
+ 1 403 221 0915
jeff@howardgroupinc.com

Natasha Roberton
VP Marketing, QYOU Media
+49 152 2254 7680​
tash@qyoutv.com

 

 

LGC Capital Signs Definitive Agreement to Acquire Strategic Interest in Licenced Australian Medical Cannabis Company – Little Green Pharma

TSX Venture Exchange authorizes LGC to proceed to closing of the transaction, scheduled for Tuesday, October 10, 2017

MONTREALOct. 5, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC”) is pleased to announce that it has entered into a definitive Subscription Agreement with licenced Australian Medical Cannabis company Habi Pharma Pty Ltd of Perth, Australia, doing business as “Little Green Pharma”, for the acquisition of a strategic interest in Little Green Pharma, as announced on September 26, 2017. LGC is also pleased to announce that the TSX Venture Exchange has authorized LGC to proceed to the closing of the transaction, which is scheduled to take place on Tuesday, October 10, 2017.

Little Green Pharma is one of the few licenced companies in Australiaauthorized to cultivate and produce Medical Cannabis within Australia.

Little Green Pharma (www.lgpharma.com.au) has advised LGC that it plans to commence cultivation and production of one of the first clean locally-grown Medical Cannabis products for use solely within Australia, giving hope and relief to those suffering from certain debilitating illnesses. Little Green Pharma’s patented technology aims to control the medicinal cannabis particle size encapsulated in the liposomes to optimise the bio-availability so the cannabinoids are readily absorbed into the bloodstream. This enables the resulting preparation to achieve desired therapeutic results with significantly lower cannabinoid doses, when compared to other forms of medicinal cannabis. Little Green Pharma’s patented process significantly reduces production costs, enabling Little Green Pharma to be more competitive in the market.

“The signing of a definitive Subscription Agreement and approval by the TSX Venture Exchange to acquire this strategic initial interest in Little Green Pharma in Australia are truly landmarks for LGC Capital, as we seek to expand the Company’s global footprint in the fast-growing legalized medical cannabis industry” John McMullen, LGC’s CEO commented. “We are pleased to be given the opportunity to be a key strategic shareholder of Little Green Pharma as it moves towards commercial production in the highly regulated and blue-chip Australian market. We are also very excited about Little Green Pharma’s advanced patented technology.”

Fleta Solomon, Little Green Pharma’s Managing Director, commented; “There is no doubt that LGC Capital is going to be a strong strategic partner as we expand the company and its opportunities.”

The details of LGC’s agreement to invest in Little Green Pharma are as follows:

  1. At closing, LGC will subscribe for 2,161,091 shares of Little Green Pharma, representing an initial 4.99% of its issued and outstanding shares, by paying AUD $432,218 and issuing 5,660,000 LGC common shares to Little Green Pharma at a deemed issue price of $0.11 per share.
  2. Subject to the issuance by Little Green Pharma of shares to various third parties, LGC will subscribe for a further 752,937 shares of Little Green Pharma for cash consideration of AUD $150,587, so as to maintain its shareholding of 4.99% in Little Green Pharma.
  3. Subject to certain Australian regulatory approvals, which are currently in progress, and subject to approval by Little Green Pharma in its sole discretion, LGC may further subscribe, at its option, for additional shares of Little Green Pharma in order to increase its shareholding to a maximum of 19.03%. In the event that this option is exercised, LGC will subscribe for a maximum of 4,585,972 shares of Little Green Pharma for maximum cash consideration of AUD $917,194.

Note: On October 4, 2017, the Bank of Canada’s daily average exchange rate for the Australian dollar was AUD $1.00 = CAD $0.9802.

Closing of the transaction with Little Green Pharma is subject to standard conditions.


About LGC (http://www.lgc-capital.com)

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.

For further information please contact:

LGC Capital:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640;

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”), its operations, strategy, investments, financial performance and condition. These statements generally can be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC, including any investment in the Medical Cannabis sector, could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2016, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and LGC has no obligation to update such statements, except to the extent required by applicable securities laws.

Information Relating to Little Green Pharma
All information contained in this news release relating to Little Green Pharma has been provided to LGC by Little Green Pharma. LGC has relied upon this information without having made independent inquiries as to its accuracy or completeness and assumes no responsibility for any inaccuracy or incompleteness of such information.

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Canada Jetlines Commences Trading on the OTCQB

VANCOUVER, BC (October 02, 2017) – Canada Jetlines Ltd. (TSX VENTURE: JET)(the “Company” or “Jetlines“) is pleased to announce that further to its press release of September 13, 2017 it has obtained final approval for trading on the OTCQB under the ticker symbol JETMF and will commence trading tomorrow at market open on Tuesday, October 3, 2017.

The OTCQB provides more efficient access to U.S. investors, helping Canadian companies to build shareholder value with a goal of enhancing liquidity and share valuation. In addition, investors have access to more transparent pricing information through the availability of premium Real-Time Level 2 quotes. This, in turn, leads to more efficient trading for investors. Through trading on the OTCQB, companies can engage a far greater network of U.S. investor, data distributors and media partners, ensuring U.S. investors have access to the same high-quality information that is available to investors in Canada, but through U.S. platforms and portals used to conduct research.

The Company further announces that it has now received TSX Venture Exchange approval for, and has completed, the issuance 250,000 common voting shares to Echelon Wealth Partners Inc. as payment for certain advisory services that were provided to the Company. The issued common voting shares will be subject to a statutory four month hold period that expires February 3, 2018.

About Canada Jetlines Ltd.

Canada Jetlines is set to become Canada’s first ultra-low cost carrier (ULCC) airline, with plans to operate flights across Canada and provide non-stop service from Canada to the United States, Mexico and the Caribbean. Jetlines is led by a board and management team with extensive experience and expertise in low-cost airlines, start-ups and capital markets. The Company was granted an unprecedented exemption from the Government of Canada that will permit it to conduct domestic air services while having up to 49% foreign voting interests.

Jetlines plans to operate modern Boeing 737-800NG aircraft in a 189 seat, all-coach configuration. Jetlines believes that Canadians deserve to have affordable low fares with the added convenience of operating from secondary airports. Additional services for baggage, seat selection and onboard beverages will be available to customers for an additional charge. Jetlines is planning to begin ticket sales through its website www.jetlines.ca in Spring 2018 and targeting start of flight operations for Summer 2018, subject to government approval.

For more information on Jetlines, please visit our website at www.jetlines.ca.

ON BEHALF OF THE BOARD

“Mark J. Morabito”
Executive Chairman


Contact Information

For more information, please contact:
The Howard Group Inc.
Tel: (403) 221-0915
Toll Free: 1-888-221-0915
Jeff Walker:jeff@howardgroupinc.com

Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking information” concerning anticipated developments and events that may occur in the future. Forward looking information contained in this news release includes, but is not limited to, statements with respect to the business plan, ticket sales and future airline operations of the Company.

In certain cases, forward-looking information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance. Forward-looking information contained in this news release is based on certain factors and assumptions regarding, among other things, the accuracy, reliability and applicability of the Jetlines’ business model; the timely receipt of governmental approvals, including the receipt of approval from regulators in Canada, the United States, Mexico and other jurisdictions where Jetlines may operate; the timely commencement of operations by Jetlines and the success of such operations; the ability of Jetlines to implement its business plan as intended; the legislative and regulatory environments of the jurisdictions where the Jetlines will carry on business or have operations; the impact of competition and the competitive response to the Jetlines’ business strategy; and the availability of aircraft. While the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect.

Forward looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors include risks related to acts of God, the impact of general economic conditions, changing domestic and international airline industry conditions, volatility of fuel prices, increases in operating costs, terrorism, pandemics, currency fluctuations, interest rates, risks specific to the airline industry, the ability of management to implement Jetlines’ operational strategy, the ability to attract qualified management and staff, labour disputes, regulatory risks, including risks relating to the acquisition of the necessary licenses and permits, financing, capitalization and liquidity risks, including the risk that the financing necessary to fund operations may not be obtained and the additional risks identified in the “Risk Factors” section of the Company’s reports and filings with applicable Canadian securities regulators.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information. The forward-looking information is made as of the date of this news release. Except as required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this release.

Electra Meccanica Announces First SOLO Manufacturing Agreement

VANCOUVER, Oct. 2, 2017 – ElectraMeccanica Vehicles Corp. (OTCQB: ECCTF) announced today that it has signed a manufacturing agreement with Zongshen Industrial Group Co., Ltd to produce 75,000 SOLO all-electric vehicles over the next three years. Specifically, the plan calls for the production of 5,000 SOLOs in 2018; 20,000 in 2019; and 50,000 in 2020. This agreement pairs one of the world’s leading industrial manufacturing conglomerates with a preeminent and forward-thinking company in Electra Meccanica.

“Renewable, clean energy-powered and Artificial Intelligence-driven transportation is the direction of the strategic transformation of Zongshen Industrial Group Co., Ltd. We are pleased to work and move forward together with Electra Meccanica, and are confident about our ability and capacity to reach this goal”, said Mr. Hu, the CEO of Zongshen Industrial Group.

“We are thrilled that Zongshen has joined us in leading the clean energy charge and partnered with us in the production of our innovative, new SOLO,” said Jerry Kroll, CEO, ElectraMeccanica Vehicles Corp. “We have thousands of orders on the books and we now have the manufacturing capacity to begin filling these orders for our customers.”

The SOLO made its world debut in 2016 and to date has amassed combined corporate and retail orders totaling over 20,000 units, representing close to $400 million CAD in anticipated purchase price value. The SOLO’s unique design is powered by a 16.1 kWh lithium-ion battery and the drive system is tuned for both speed and mobility. With a range of 160 km (100 miles), and a top speed of 130 kph (80 mph), the SOLO delivers superior performance and spirited driving. Electra Meccanica is currently offering dealer opportunities and is accepting fully-refundable $250 deposits for the SOLO, and $1,000 deposits on the Tofino, at EMVauto.com.

About ElectraMeccanica Vehicles Corp.
Electra Meccanica (OTCQB: ECCTF) designed and builds the innovative, all-electric SOLO and the Tofino all-electric sport coupe. Both vehicles are tuned for the ultimate driving experience while making your commute more efficient, cost-effective and environmentally friendly.

More information can be found at EMVauto.com.

About Zongshen Industrial Group Co., Ltd.

Zongshen Industrial Group Co., Ltd., a diversified investment holding group, engages in industrial equipment manufacturing, real estate, automobile sales, financial, and mining businesses. The company provides small-size thermal power machinery, motorcycle engines, general-purpose gasoline engines, diesel engines, truck engines, parts and components of automobile, various agricultural and forestry machinery, special powers, multi-fuel powers, marine propulsion powers, etc.; and gasoline and electric motorcycles, and three-wheelers, as well as components and parts of motorcycles, vehicles and IT, etc. It also engages in the development of commercial and residential, education industry, automobile and motorcycle industrial chain aftermarket, elderly care and rehabilitation, and financial and international exchange and cooperation complexes. Zongshen Industrial Group Co., Ltd. was formerly known as Zongshen Motorcycle Science & Technology and changed its name to Zongshen Industrial Group Co., Ltd. in January 2003. The company was founded in 1992 and is based in Chongqing, China. It has operations in Europe, America, the Middle East, Southeast Asia, and Africa.


Investor Relations Information

Sam Woolf
Investor Relations Coordinator;
Telephone: 604-715-7607
Email: sam@electrameccanica.com

Jeff Walker
The Howard Group Inc.;
Telephone: 403-221-0915
Email: jeff@howardgroupinc.com

Media Contact Information:
Jeff Holland, Head of Media Relations
Tel. 562-640-1758
Email: JeffHolland@electrameccanica.com


Cautionary Statement Regarding “Forward-Looking” Information
Some of the statements contained in this press release are forward-looking statements and information within the meaning of applicable securities laws. Forward-looking statements and information can be identified by the use of words such as “expects”, “intends”, “is expected”, “potential”, “suggests” or variations of such words or phrases, or statements that certain actions, events or results “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements and information are not historical facts and are subject to a number of risks and uncertainties beyond the Company’s control. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this news release. Accordingly, readers should not place undue reliance on forward-looking statements. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, except as may be required by law.

FLYHT Announces New Chief Financial Officer and Schedules Third-Quarter 2017 Financial Results Conference Call

Calgary, Alberta – October 2, 2017 – FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) is pleased to announce the appointment of Derek Payne as Chief Financial Officer. Paul Takalo will remain Interim Chief Financial Officer until Mr. Payne assumes his new position on November 6, 2017. In the interim, Mr. Payne will serve as a financial consultant to FLYHT.

“I’m delighted to have Derek join FLYHT. He has over 19 years of experience in senior financial roles at high-growth public companies, including over nine years of experience in the aviation industry. Derek also brings a wealth of experience with regard to the Canadian and U.S. capital markets,” remarked Thomas Schmutz, FLYHT’s Chief Executive Officer. “I wish to thank Paul Takalo for the strong contributions he has made as interim CFO. We will continue to benefit from Paul’s invaluable guidance, as he will remain on FLYHT’s Board of Directors.”

Prior to his appointment as FLYHT’s Chief Financial Officer, Mr. Payne was Chief Financial Officer at Calgary-based DIRTT Environmental Solutions. Previously he was Chief Financial Officer at FilterBoxx Water and Environmental; Treasurer and Vice President of Finance at WestJet Airlines Ltd., where he also held a term position as Co-acting CFO. Mr. Payne obtained his Chartered Professional Accountant designation in 1996 and holds a Bachelor of Commerce degree from the University of Saskatchewan. Since June of 2012, Mr. Payne has been a volunteer board member of Hospice Calgary and currently serves as the organization’s Board Treasurer and Chair of its Finance Committee.

Third-quarter Financial Results Conference Call
FLYHT will host a live conference call to discuss its third-quarter 2017 financial results on November 3, 2017 at 7:00am MDT (9:00am EDT, 6:00am PDT).

On the conference call, FLYHT’s CEO Thomas Schmutz and Interim CFO Paul Takalo will discuss the Company’s quarterly financial results and answer caller’s questions.

To access the conference call by phone within Canada and the U.S.A. the toll-free number is 1-800-319-4610. Outside Canada and the U.S.A., dial 1-604-638-5340. (Callers should dial in five to 10 minutes prior to the scheduled start time).

Individuals wishing to ask a question during the conference call, can do so by pressing *1. Questions can be emailed to investors@flyht.com.

An archive of the conference call will be posted on the Presentations and Webcasts section of FLYHT’s website as soon as it is available from the conference call provider: http://flyht.com/presentation-and-webcast/

About FLYHT Aerospace Solutions Ltd.

FLYHT’s mission is to improve aviation safety, efficiency and profitability (located in Calgary, Canada; publicly traded as: FLY:TSX.V; FLYLF:OTCQX). Airlines, leasing companies, fractional owners and original equipment manufacturers have installed the Automated Flight Information Reporting System (AFIRS™) on their aircraft to capture, process and stream aircraft data with real-time alerts. AFIRS sends this information through satellite networks to the UpTime™ cloud-based data center, which provides aircraft operators with direct insight into the operational status and health of their aircraft and enables them to take corrective action to maintain the highest standard of operational control.


Contact Information

FLYHT Aerospace Solutions Ltd.
Paul Takalo
Interim Chief Financial Officer
403-291-7425
ptakalo@flyht.com
Investor Relations – The Howard Group
Dave Burwell
Vice President
(888) or (403)-221-0915
dave@howardgroupinc.com

 

Join us on social media!

www.facebook.com/flyht
www.twitter.com/flyhtcorp
www.slideshare.net/flyhtcorp
www.youtube.com/flyhtcorp
www.flyht.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

LGC Capital Signs Binding Term Sheet to Acquire Strategic Interest in Licenced Australian Medical Cannabis Company – Little Green Pharma

MONTREALSept. 26, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC”) announces that it has entered into a binding term sheet with Habi Pharma Pty Ltd of Perth, Australia, doing business as “Little Green Pharma“, which provides that LGC will acquire an initial strategic 4.99% interest in Little Green Pharma, one of the few licenced companies authorized to cultivate and produce Medical Cannabis within Australia. The binding term sheet provides that LGC has the option to increase its interest in Little Green Pharma to a maximum of 19.03%, subject to a number of conditions, including Australian Government regulatory approvals.

Little Green Pharma (www.lgpharma.com.au) has advised LGC that it plans to commence cultivation and production of one of the first clean locally-grown Medical Cannabis products for use solely within Australia, giving hope and relief to those suffering from certain debilitating illnesses.

John McMullen, LGC’s CEO, commented; “This will be LGC’s first investment into the legalized Medical Cannabis sector in the Asia-Pacific region. This will be an important investment initiative for LGC in the region as Little Green Pharma is one of the few companies in Australia licenced to cultivate and produce Medical Cannabis. Australiahas now legalized the use of Medical Cannabis and Little Green Pharma plans to commence production shortly.”

Fleta Solomon, Little Green Pharma’s Managing Director, commented; “We look forward to having LGC on board as a new strategic long-term shareholder in Little Green Pharma. LGC’s support and funding will assist in providing the necessary working capital to allow Little Green Pharma to cultivate and produce our product range for Australian patients in the coming months.”

Binding Term Sheet

The binding term sheet between LGC and Little Green Pharma provides that:

  1. LGC will subscribe for 2,161,091 shares of Little Green Pharma, representing 4.99% of its issued and outstanding shares, by paying AUD $432,218 and issuing 5,660,000 LGC common shares to Little Green Pharma at a deemed issue price of $0.11 per share.
  2. Subject to the issuance by Little Green Pharma of shares to various third parties, LGC will subscribe for a further 752,937 shares of Little Green Pharma for cash consideration of AUD $150,587, so as to maintain its shareholding of 4.99% in Little Green Pharma.
  3. Subject to approval by Little Green Pharma in its sole discretion, LGC may further subscribe, at its option, for additional shares of Little Green Pharma in order to increase its shareholding to a maximum of 19.03%.  In the event that this option is exercised, LGC will subscribe for a maximum of 4,585,972 shares of Little Green Pharma for maximum cash consideration of AUD $917,194.

On September 25, 2017, the Bank of Canada’s daily average exchange rate for the Australian dollar was AUD $1.00 = CAD $0.9806.

Closing Conditions

Closing of the transaction with Little Green Pharma is subject to standard conditions, including the negotiation and signing of a definitive subscription agreement between LGC and Little Green Pharma. LGC cannot give any assurance that the transaction with Little Green Pharma will close in accordance with the terms and conditions of the binding term sheet or at all. Further, LGC cannot proceed with any investment in Little Green Pharma prior to obtaining formal approval from the TSX Venture Exchange with respect thereto. Although LGC has commenced the process for obtaining formal approval from the TSX Venture Exchange, LGC cannot give any assurance that it will be able to obtain such approval.

LGC will require the approval of the Australian Government’s Office of Drug Control (ODC) in order to increase its interest in Little Green Pharma to more than 4.99% and may require the approval of the Australian Foreign Investment Review Board (FIRB) to increase its interest in Little Green Pharma to more than 15%. Little Green Pharma has agreed to provide all necessary assistance and support to LGC with respect to such government approvals. LGC cannot give any assurance that it will be able to obtain such approvals, to the extent necessary.

Little Green Pharma

LGC understands that Little Green Parma is a privately-owned company based in Western Australia and that in April 2017, Little Green Pharma was granted one of the few licenses in Australia by the Australian Government’s Office of Drug Control (ODC) to cultivate and produce Medicinal Cannabis for Australian patients from June 1, 2017.

Little Green Pharma has stated that its goal is to make safe, reliable and cost-effective Medicinal Cannabis products available to Australians through approved medical practitioners, and that it will produce a range of Medical Cannabis preparations with differing cannabinoid profiles from multiple plant varieties.
Little Green Pharma has advised LGC that it has an advanced manufacturing technology for producing Medicinal Cannabis for oral administration. Its process ensures high bio-availability of the active cannabinoids, meaning that a therapeutic effect can be achieved with precise dosage control and with significantly lower cannabinoid doses.

Little Green Pharma has stated that its manufacturing process can maintain the integrity of CBD-A and THC-A if required, avoiding the carboxylation of important cannabinoids. Preparations will meet strict regulatory standards for medicinal cannabis specifications ensuring a clean, high-quality product. All growing, production and good manufacturing practice is subject to the terms of the Australian federal licence aimed at security and quality assurance by the relevant regulatory bodies.

The Australian Medical Cannabis Market

Little Green Pharma has advised LGC that Australia passed federal legislation in 2016 aimed at permitting the use of Medicinal Cannabis via a tightly-controlled licensed medical prescription system.

In March 2016The White Paper, entitled Medicinal Cannabis in Australia: Science, Regulation & Industry, was developed by the University of Sydney Business School’s Community Placement Program. Its publication followed the news that the Australian Government would shortly allow the cultivation of cannabis in Australia for medical or scientific purposes.

As the first-ever White Paper that analyses the medicinal cannabis industry in Australia, the paper examines international experiences and approaches, supply chain economics, quantities of cannabis required and potential regulatory dynamics. It also serves as a framework for the industry to commence engaging key stakeholders such as the Australian Government and the medical community.

The University of Sydney summary of the White Paper can be viewed via the below link:

http://sydney.edu.au/news-opinion/news/2016/03/29/legalising-medicinal-cannabis-would-create–100-million-industry.html

The White paper can be viewed at:

http://mgcpharma.com.au/wp-content/uploads/2016/03/mgc_whitepaper_final-sml.pdf

Highlights of the White Paper:

  • Australia would need to produce 8,000 kg of medicinal cannabis per year to service the existing market.
  • Australian market currently estimated to be worth AUD $100 million –AUD $150 million per annum, and is likely to grow significantly in the next decade.
  • Medical Cannabis has the potential to help tens of thousands of patients suffering from a wide range of medical conditions such as Multiple Sclerosis, Epilepsy, Cancer, and Severe and Chronic Pain.
  • Up to 51,000 square metres of greenhouse space – almost three times the size of the Sydney Cricket Ground – would be needed to produce the amount of cannabis required to meet demand.

About LGC (http://www.lgc-capital.com)

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.

For further information please contact:

LGC Capital:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640;

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”), its operations, strategy, investments, financial performance and condition. These statements generally can be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC, including any investment in the Medical Cannabis sector, could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2016, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and LGC has no obligation to update such statements, except to the extent required by applicable securities laws.

Information Relating to Little Green Pharma
All information contained in this news release relating to Little Green Pharma has been provided to LGC by Little Green Pharma. LGC has relied upon this information without having made independent inquiries as to its accuracy or completeness and assumes no responsibility for any inaccuracy or incompleteness of such information.

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

LGC Capital Ltd. Exits All Investment Activity Associated With Cuba To Focus On Its Global Medical Cannabis Initiatives And Other Investment Opportunities

Montreal, Québec – September 26, 2017 – LGC Capital Ltd. (TSXV: LG) (“LGC”) announces that its Board of Directors has resolved to immediately exit all current investments, partnerships and joint venture arrangements with companies or entities that have any business activities relating to Cuba.

While LGC continues to be positive towards the investment opportunities in Cuba, regrettably the U.S. government embargo on Cuba places onerous restrictions on LGC’s critical ability to transact with key banking and financial market institutions. These restrictions have also severely limited LGC’s ability to broaden its investor and shareholder base.

LGC’s focus has changed considerably since its initial investment in the legalized Medical Cannabis sector in June 2017. LGC will now continue with its growth strategy of increasing its investment footprint in this fast-growing and globally-expanding sector, with the exception of investments in businesses operating in the United States.

LGC will also review new investment opportunities in other sectors that the Board considers may add value for shareholders. These new investments will not carry the burden of limitations and restrictions from the financial community as Cuban investments and businesses currently do.

John McMullen, LGC’s CEO, commented:

It’s now time to open up LGC to the wider investment and banking community outside of Canada by completely exiting our business initiatives and joint ventures in Cuba.

“This move, although regrettable, should enable LGC to broaden its shareholder base and establish corporate advisory and banking relationships in jurisdictions that previously would not deal with LGC due to restrictions placed on these organizations by the U.S. government. This corporate decision should, for the first time, open up LGC to potential U.S. investors. We will now actively engage with our advisors in Canada to notify international brokerage firms, banks and share-clearing agencies of our decision to exit Cuba.

“LGC still sees tremendous investment opportunities in Cuba, but will no longer invest in any company that has activities in Cuba”, Mr. McMullen concluded.

LGC cannot proceed with any investment in a business or operation related to the Medical Cannabis industry prior to obtaining formal approval from the TSX Venture Exchange with respect thereto.

About LGC (http://www.lgc-capital.com)

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: LG). LGC’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services.

For further information please contact:

LGC Capital:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640;

FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements with respect to LGC Capital Ltd. (“LGC”), its operations, strategy, investments, financial performance and condition. These statements generally can be identified by use of forward-looking words such as “may”, “will”, “expect”, “estimate”, “anticipate”, “intends”, “believe” or “continue” or the negative thereof or similar variations. The actual results and performance of LGC, including any investment in the Medical Cannabis sector, could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under “Risk Factors and Risk Management” in LGC’s Management’s Discussion and Analysis for the fiscal year ended September 30, 2016, as filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable to LGC and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and LGC has no obligation to update such statements, except to the extent required by applicable securities laws.

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Permex Petroleum Corporation Announces Closing Oversubscribed $2,831,000.00 Pre-IPO Round and execution of Purchase & Sale Agreement

VANCOUVER, BRITISH COLUMBIA (September 22, 2017) – Permex Petroleum Corporation (“Permex” or the “Corporation”) and Permex Petroleum Limited Partnership (the “Partnership”) are pleased to announce that they have completed an over-subscribed private placement of 7,007,500 common shares (each, a “Share”) at a price of $0.40 per Share to raise total gross proceeds of $2,803,000.00 (the “Private Placement”). Permex Petroleum Corporation directly raised $330,000.00 in its private placement and indirectly raised $2,473,000.00 through Permex Petroleum Limited Partnership as takeover of units.

Also, the Company is pleased to announce that it has signed a Purchase and Sale Agreement (the “PSA”) with Nordstrand Engineering Inc. (“Nordstrand Engineering”) to acquire Nordstrand Engineering’s Henshaw and Oxy Oil & Gas properties, Wells and Leaseholds located in Eddy County, New Mexico. These assets fall within the Delaware Basins. With this acquisition, the Company will own over 5,500 Net acres of producing oil and gas assets stretched across North West Texas and South East New Mexico. The Company intends to carry on discounted acquisitions and to implement a conservative yet aggressive development plan optimizing the production from its current assets as well as an aggressive drilling program on some of its assets. The directors of the Company have extensive and highly successful track records on discounted acquisitions, enhancement, optimization of fields, secondary recovery and infill drilling programs.

With this acquisition, the Company will own over 5,500 Net acres of producing oil and gas assets stretched across North West Texas and South East New Mexico. The Company intends to carry on discounted acquisitions and to implement a conservative yet aggressive development plan optimizing the production from its current assets as well as an aggressive drilling program on some of its assets. The directors of the Company have extensive and highly successful track records on discounted acquisitions, enhancement, optimization of fields, secondary recovery and infill drilling programs.

“We’re very pleased to execute the PSA on our new Delaware Basin acquisition from Nordstrand Engineering and to concurrently complete a successful oversubscribed offering. These new properties are not only our entry into the Delaware Basin, but provide us with enough drilling and development opportunity for years to come.” said Mehran Ehsan, CEO of the Company. “The response to this Pre-IPO round, including timing and capital structure has been very encouraging and we look forward to our efforts to enhance shareholder value upon a successful listing on a public exchange”

Private Placement

Pursuant to the terms of the Private Placement, any direct subscribers investing into Permex Petroleum Corporation agreed to participate in the Company’s initial public offering on the Canadian Securities Exchange (the “IPO”) by subscribing for an aggregate subscription amount equal to their investment in the Private Placement (which IPO will be conducted at a price of Cdn$0.50 per share). A total of $224,240.00 in finders’ fees and commissions were paid; however, no warrants or options were issued in connection with the Private Placement. The Shares issued pursuant to the Private Placement are subject to a contractual hold period under the terms of the subscription agreement for a period of 12 months from the closing date.

The funds raised pursuant to the Private Placement are expected to be used by the Company to fund the Company’s operations, to identify complementary asset acquisitions, and for general working capital expenses.

About Permex Petroleum Corporation (www.permexpetroleum.com)

Permex Petroleum Corporation is a Junior Oil & Gas Company with a focus on low risk producing oil and natural gas assets with significant upside growth opportunities in the State of New Mexico and Texas. The Corporation is seeking to be a listed on the Canadian Stock Exchange through an Initial Public Offering (“IPO”) in the fourth quarter of 2017.

For further information please contact:

Permex Petroleum
Mehran Ehsan, Chief Executive Officer
Tel: +1(604) 259-2525, Ext: 101
Email: mehsan@permexpetroleum.com

Or for Investor Relations please contact:

The Howard Group Inc.
Dave Burwell
Tel: +1(403) 221-9015
Toll Free in Canada: 1-888-221-0915
Email: dave@howardgroupinc.com

Forward Looking Statements
This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities described herein in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or the securities laws of any state of the United States and may not be offered or sold within the United States (as defined in Regulation S under the U.S. Securities Act) unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

This press release contains forward-looking statements within the meaning of applicable securities laws. More particularly, this press release contains forward-looking statements concerning the proposed terms and timing of the Offering,  the expected use of proceeds from the Offering, the Corporation’s anticipated IPO timing and the Corporation’s anticipated business activities, including future acquisitions. The forward-looking statements contained in this document are based on certain key expectations and assumptions made by the Corporation regarding, among other things: oil and natural gas prices; production rates and reserve volumes; the ability to add production and reserves through exploration and development activities; the benefits of future acquisitions; capital expenditures; the timely receipt of required regulatory approvals; the availability and cost of labour and other industry services; interest and foreign exchange rates; the continuance of existing or proposed tax and royalty regimes; current and anticipated industry conditions; and current laws and regulations continuing in effect or changing as proposed. Although the Corporation believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Corporation can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to: the volatility of oil and natural gas prices; uncertainties in capital markets; the failure to obtain necessary regulatory approvals; the risk that the transactions described herein are delayed or are not completed; changes in government regulations that affect the oil and gas industry; variations in interest rates and foreign exchange rates; availability and cost of gathering, processing and pipeline systems; depletion of reserves; risks associated with the exploitation of properties and ability to acquire reserves; changes in income tax or other laws or government incentive programs; the cost of developing and operating the Corporation’s assets; uncertainties associated with estimating oil and natural gas reserves; and risks associated with acquiring, developing and exploring for oil and natural gas and other aspects of the Corporation’s operations. The forward-looking statements contained in this press release are made as of the date hereof and the Corporation undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

LGC Capital Ltd. Updates Corporate Presentation

MONTREALSept. 19, 2017  – LGC Capital Ltd. (TSXV: LG)(“LGC“) announces that it has updated its Corporate Presentation, which is available on LGC’s web site (www.lgc-capital.com), as well as certain information on the web site to reflect the changing nature of its businesses and investments.

The Corporate Presentation and web site, as updated, specify that LGC’s joint venture to grow and distribute medical and recreational cannabis products in South Africa is with AfriAg (Pty) Ltd., which is 40% owned by AfriAg Global plc, a company listed on the fully-regulated NEX Growth Market in London. They also specify that LGC and its joint venture partner AfriAg (Pty) Ltd. signed an agreement with South Africa’s House of Hemp (http://houseofhemp.co.za) under which the joint venture has the sole and exclusive right to acquire a 60% economic and beneficial interest in House of Hemp, as announced on June 26, 2017.

The Corporate Presentation and web site, as updated, are consistent with LGC’s press releases issued on June 26, 2017 and July 18, 2017, respectively, both of which are available under LGC’s profile on SEDAR at www.sedar.com and via LGC’s web site. LGC has made certain other conforming changes to the Corporate Presentation.

Mr. David Lenigas, who is Co-Chairman and a director of LGC, is also Executive Chairman of AfriAg Global plc and a director of AfriAg (Pty) Ltd.

About LGC (http://www.lgc-capital.com)

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: QBA). LGC Capital’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services, many of which have some exposure to high growth Cuban business opportunities and some that have no exposure to Cuba at all. LGC Capital has now entered into the agricultural space and the medical cannabis sector in southern Africa through its new joint venture with AfriAg and is seeking new investments opportunities in this sector not only in southern Africa but also elsewhere in the world.

For further information please contact:

LGC Capital:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640;

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FLYHT to Work with Inmarsat for AFIRS Trial Flight

Announcement made by Inmarsat September 19

Calgary, Alberta – September 19, 2017 – FLYHT Aerospace Solutions Ltd. (TSX-V: FLY) (OTCQX: FLYLF) (the “Company” or “FLYHT”) is pleased to announce a flight trial with Inmarsat, and would like to bring attention to an Inmarsat press release titled Inmarsat to demonstrate advanced SwiftBroadband-Safety capabilities in flight trial with FLYHT on September 19, 2017. This trial will demonstrate the use of FLYHT’s Automated Flight Information Reporting System (AFIRS™) to send data to the UpTime™ Cloud management platform via Inmarsat’s secure IP broadband platform, SwiftBroadband-Safety (SB-S).

Tom Schmutz, FLYHT’s Chief Executive Officer, said: “This is a great opportunity for FLYHT to work directly with Inmarsat and install our newest technology solution on an aircraft that can test the “corner cases” for Inmarsat’s “Black Box in the Cloud” capability. FLYHT brings significant capability in the areas of Autonomous Distress Tracking and the Timely Recovery of Flight Data and we look forward to testing our solution with Inmarsat and the other trial partners.”

The evaluation will commence in 2017 and will be conducted using an experimental trial aircraft, to enable a range of conditions to be evaluated. It will validate the capabilities of SB-S to provide secure, high-speed global connectivity to enhance airline safety, security and operations. FLYHT will provide equipment and software, including its AFIRS product and UpTime Cloud flight management server, together with technical support for the flight trial.

About FLYHT Aerospace Solutions Ltd.

FLYHT’s mission is to improve aviation safety, efficiency and profitability (located in Calgary, Canada; publicly traded as: FLY:TSX.V; FLYLF:OTCQX). Airlines, leasing companies, fractional owners and original equipment manufacturers have installed the Automated Flight Information Reporting System (AFIRS™) on their aircraft to capture, process and stream aircraft data with real-time alerts. AFIRS sends this information through satellite networks to the UpTime™ cloud-based data center, which provides aircraft operators with direct insight into the operational status and health of their aircraft and enables them to take corrective action to maintain the highest standard of operational control.


Contact Information

FLYHT Aerospace Solutions Ltd.
Paul Takalo
Interim Chief Financial Officer
403-291-7425
ptakalo@flyht.com
Investor Relations – The Howard Group
Dave Burwell
Vice President
(888) or (403)-221-0915
dave@howardgroupinc.com

 

Join us on social media!

www.facebook.com/flyht
www.twitter.com/flyhtcorp
www.slideshare.net/flyhtcorp
www.youtube.com/flyhtcorp
www.flyht.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Electra Meccanica Announces Corporate Letters Of Intent and Order Book Amounts

VANCOUVERSept. 18, 2017 – ElectraMeccanica Vehicles Corp. (OTCQB: ECCTF) (“Electra Meccanica” or the “Company“) is pleased to announce the volume and value of the Company’s order book and letters of intent as of September 14th, 2017.  In total, Electra Meccanica has received 9 letters of intent from companies around the world (corporate orders) – one from Asia, two from Europe and six from North America.

The combined corporate and retail orders amount to 19,845 SOLO electric vehicles and 24,202 Tofino electric vehicle models, totalling $1.604 billion (CDN) in anticipated purchase price value.*

Although the Company has started very limited production at its Vancouver, British Columbia, facility, it is presently expected that larger scale production of the SOLO will begin by the end of the first half of 2018.  It is also presently expected that large scale production of the Tofino and deliveries will begin in 2019.**

“After many years of research and development perfecting our first in a long line of next generation electric vehicles, we believe that we are delivering the affordable solution to the masses and that our company will be a global leader in this indisputable growing market,” Jerry Kroll, CEO further stated. “We are confident that these orders demonstrate the market’s interest in our electric vehicle products.”

As of September 14th, the Company has received retail orders for 579 SOLOs and 102 retail Tofinos with the balance order volume of each product being corporate orders.All retail orders of the SOLO require a $250 refundable deposit, while the Tofino orders require a $1,000 refundable deposit. Corporate orders require a Letter of Intent and all orders are non-binding.

About ElectraMeccanica Vehicles Corp.

Electra Meccanica designs and builds the innovative, all-electric SOLO and the Tofino all-electric sport coupe.  Both vehicles are tuned for the ultimate driving experience while making your commute more efficient, cost-effective and environmentally friendly.

More information can be found at EMVauto.com.


Investor Relations Information

Sam Woolf
Investor Relations Coordinator;
Telephone: 604-715-7607
Email: sam@electrameccanica.com

Jeff Walker
The Howard Group Inc.;
Telephone: 403-221-0915
Email: jeff@howardgroupinc.com


Safe Harbor Statements
* The customer may at any time, for any reason, cancel their order and have their deposit returned. Electra Meccanica does not consider any order as being secured until the vehicle has been delivered and full receipt of the remaining balance of the vehicle purchase price has been received.

** The order value figures assume that the Company will have the manufacturing capability of producing the required number of SOLOs and Tofinos to satisfy such order numbers which, if Electra Meccanica is not able to guarantee, such future manufacturing capability and actual results may differ materially from those anticipated. It is also presently expected that any large scale production of either the SOLO or the Tofino will be the result of a long-term joint venture or similar relationship which the Company continues to work on formally establishing.

Except for the statements of historical fact contained herein, the information presented in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian securities laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “anticipates”, “estimates”, “projects”, “expects”, “contemplates”, “intends”, “believes”, “plans”, “may”, “will”, or their negatives or other comparable words) are not statements of historical fact and should be viewed as “forward-looking statements”. Such forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, the prices of other electric vehicles, costs associated with manufacturing vehicles, the availability of capital to fund business plans and the resulting dilution caused by the raising of capital through the sale of shares, changes in the electric vehicle market, changes in government regulation, developments in alternative technologies, inexperience in servicing electric vehicles, labour disputes and other risks of the electric vehicle industry including, without limitation, those associated with the delays in obtaining governmental approvals and/or certifications. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended.

There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release.

Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable law. Such forward-looking statements reflect our current views with respect to future events and are subject to certain risks, uncertainties and assumptions, including, the risks and uncertainties outlined in our most recent financial statements and reports and registration statement filed with the United States Securities and Exchange Commission (the “SEC”) (available at www.sec.gov) and with Canadian securities administrators (available at www.sedar.com). Although the Company believes that the beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance those beliefs, plans, expectations or intentions will prove to be accurate. Investors should consider all of the information set forth herein and should also refer to the risk factors disclosed in the Company’s periodic reports filed from time-to-time with the SEC. This news release shall not constitute an offer to sell or the solicitation of an offer to buy securities of the Company nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

LGC Capital Ltd. announces Director resignation

MONTREALSept. 18, 2017  – LGC Capital Ltd. (TSXV: QBA) (“LGC“) announces the resignation of Mr. Sébastien Bellefleur as a Director of the Corporation effective September 13, 2017. The Board of Directors wishes to thank Mr. Bellefleur for his contribution to LGC Capital and wishes him every success in his future endeavours.  The Corporation will initiate a search for a new director to replace Mr. Bellefleur.

About LGC (http://www.lgc-capital.com)

LGC Capital Ltd. is a Canadian incorporated public company listed on the TSX Venture Exchange (TSXV: QBA). LGC Capital’s objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services, many of which have some exposure to high growth Cuban business opportunities and some that have no exposure to Cuba at all. LGC Capital has now entered into the agricultural space and the medical cannabis sector in southern Africa through its new joint venture with AfriAg and is seeking new investments opportunities in this sector not only in southern Africa but also elsewhere in the world.

For further information please contact:

LGC Capital:
John McMullen, Chief Executive Officer
Tel: +1(416) 803-0698
Email: John@lgc-capital.com

Investor Relations contact:
The Howard Group Inc.
Dave Burwell, Vice President
Tel: +1(403) 221-9015
Toll Free in Canada: 1-888-221-0915,
Email: dave@howardgroupinc.com

London contact:
Anthony Samaha, Chief Financial Officer
Tel.: +44 (0) 20 7440 0640;

Caution Regarding Press Releases
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.